| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Timber Pharmaceuticals, Inc. | CEO & Chairman | Common Stock, par value $0.001 per share | 70,785 | $115,309 | $1.63 | 20 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TMBR | Timber Pharmaceuticals, Inc. | 20 Aug 2023 | 1 | $0 | 4 | CEO & Chairman | 22 Aug 2023, 19:46 |
| TMBR | Timber Pharmaceuticals, Inc. | 15 Apr 2023 | 1 | $0 | 4 | CEO & Chairman | 18 Apr 2023, 11:43 |
| TMBR | Timber Pharmaceuticals, Inc. | 15 Apr 2022 | 1 | $0 | 4 | CEO & Chairman of the Board, Director | 19 Apr 2022, 13:01 |
| TMBR | Timber Pharmaceuticals, Inc. | 15 Dec 2021 | 1 | +$7,686 | 4 | CEO & President, Director | 16 Dec 2021, 15:23 |
| TMBR | Timber Pharmaceuticals, Inc. | 14 Sep 2021 | 1 | $0 | 4 | CEO & President, Director | 16 Sep 2021, 16:06 |